KA34

· Calibr, a division of Scripps Research

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KA34, covering 2021-05-17 to 2021-05-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis [Phase 1]

See pricing